封面
市場調查報告書
商品編碼
1532605

線性粒子加速器市場 - 產品類型、處理類型、應用、最終用戶 - 全球預測

Linear Particle Accelerators Market - Product Type, Treatment Type, Application, End user - Global Forecast

出版日期: | 出版商: Global Market Insights Inc. | 英文 193 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於基於輻射的技術(包括醫學成像、放射治療和工業加工)的使用不斷擴大,線性粒子加速器市場規模從 2024 年到 2032 年的複合年成長率預計將達到 5.9%。包括癌症治療中心和研究機構在內的醫療保健設施的發展和現代化正在推動對先進電子直線加速器直線加速器的需求。現有設施的新安裝和升級增加了對多種最先進技術的需求。對科學和醫療基礎設施的大量投資也將在市場成長中發揮重要作用。

線性粒子加速器產業分為產品類型、技術、處理類型、應用、最終用戶和地區。

就技術而言,在醫療、工業和研究領域的多功能應用的推動下,電子領域的市場價值將在 2032 年實現利潤豐厚的複合年成長率,以滿足對精度和效率日益成長的需求。現代電子直線加速器可提供高精度的輻射傳輸,這對於需要精確劑量分佈的應用至關重要。提供增強性能的技術進步,包括更好的光束品質、更高的能量水平和更有效率的操作,將推動該領域的成長。

在應用方面,肺癌領域的線性粒子加速器產業預計將從 2024 年擴大到 2032 年。憑藉先進的影像和治療計劃能力來提高有效性和安全性,這些加速器已成為肺癌管理中的寶貴工具。

從地區來看,由於癌症發生率上升以及醫療環境中對先進治療技術的需求強勁成長,預計2024年至2032年亞太地區直線粒子加速器市場規模將出現良好成長。對醫療基礎設施和醫療設施現代化的投資不斷增加,正在推動先進粒子加速器用於診斷和治療目的的採用。政府不斷採取的開發和升級科學和醫療基礎設施的措施將有助於增加區域產品需求。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 對放射治療的需求不斷成長
      • 提高對早期癌症診斷和治療的認知
      • 先進放射療法的批准不斷增加
      • 放療優惠報銷政策
    • 產業陷阱與挑戰
      • 線性粒子加速器的高成本
      • 與輻射暴露相關的安全問題
  • 成長潛力分析
  • 未來市場趨勢
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品類型,2021 - 2032 年

  • 主要趨勢
  • 高能機
  • 中能量機
  • 低耗能機

第 6 章:市場估計與預測:按技術分類,2021 - 2032 年

  • 主要趨勢
  • X光
  • 電子
  • 質子
  • 離子束
  • 其他技術

第 7 章:市場估計與預測:按治療類型,2021 - 2032 年

  • 主要趨勢
  • 傳統直線粒子加速器
  • 立體定位放射外科及立體定位全身放射治療
  • 調強放射治療
  • 容積調製電弧療法
  • 影像導引放射治療
  • 其他治療類型

第 8 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 攝護腺癌
  • 乳癌
  • 肺癌
  • 大腸直腸癌
  • 頭頸癌
  • 其他應用

第 9 章:市場估計與預測:按最終用戶分類,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 放射科診所
  • 其他最終用戶

第 10 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 11 章:公司簡介

  • AccSys Technology, Inc.
  • Accuray Incorporated
  • Altair Technologies, Inc.
  • Brainlab AG
  • Carl Zeiss Meditec AG
  • Elekta
  • Laird Technologies, Inc.
  • MITSUBISHI HEAVY INDUSTRIES, LTD.
  • Panacea Medical Technologies Pvt. Ltd.
  • S.I.T. Sordina IORT Technologies S.p.A.
  • SHINVA MEDICAL INSTRUMENT CO., LTD.
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
  • VIEWRAY TECHNOLOGIES, INC.
  • VIVIRAD S.A.
簡介目錄
Product Code: 9664

Linear Particle Accelerators Market size is poised to record 5.9% CAGR from 2024-2032, on account of expanding usage in radiation-based technologies, including medical imaging, radiation therapy, and industrial processing. The development and modernization of healthcare facilities, including cancer treatment centers and research institutions, are driving the demand for advanced electron linacs linear accelerators. New installations and upgrades to the existing facilities are increasing the need for several state-of-the-art technologies. Significant investments in scientific and healthcare infrastructure will also play an important role in the market growth.

The linear particle accelerators industry is segmented into product type, technology, treatment type, application, end-user, and region.

In terms of technology, the market value from the electron segment will witness lucrative CAGR through 2032, driven by versatile applications in medical, industrial, and research fields to meet the increasing need for precision and efficiency. Modern electron linacs offer high precision in radiation delivery, which is crucial for applications requiring accurate dose distribution. Technological advancements to offer enhanced performance, including better beam quality, higher energy levels, and more efficient operation will push the segment growth.

With respect to application, the linear particle accelerators industry from the lung cancer segment is expected to expand from 2024 to 2032. The growth can be attributed to the rising need to offer precise, high-dose radiation delivery with minimal impacts on surrounding healthy tissues. With advanced imaging and treatment planning capabilities to enhance effectiveness and safety, these accelerators have emerged as valuable tools in the management of lung cancer.

Regionally, the Asia Pacific linear particle accelerators market size is expected to observe decent growth from 2024 to 2032, due to the rising incidence of cancer and strong growing demand for advanced treatment technologies in medical settings. The rising investments in healthcare infrastructure and modernization of medical facilities is boosting the adoption of advanced particle accelerators for diagnostic and therapeutic purposes. Growing government initiatives for developing and upgrading scientific and medical infrastructure will contribute to the regional product demand.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing demand for radiotherapy treatments
      • 3.2.1.2 Increasing awareness towards early cancer diagnosis and treatment
      • 3.2.1.3 Growing approvals for advanced radiotherapies
      • 3.2.1.4 Favourable reimbursement policies for radiotherapies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated to linear particle accelerator
      • 3.2.2.2 Safety concerns related to radiation exposure
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 High-energy machine
  • 5.3 Medium-energy machine
  • 5.4 Low-energy machine

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 X-Ray
  • 6.3 Electron
  • 6.4 Proton
  • 6.5 Ion beam
  • 6.6 Other technologies

Chapter 7 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Conventional linear particle accelerator
  • 7.3 Stereotactic radiosurgery & stereotactic body radiotherapy
  • 7.4 Intensity-modulated radiation therapy
  • 7.5 Volumetric modulated arc therapy
  • 7.6 Image-guided radiation therapy
  • 7.7 Other treatment types

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Prostate cancers
  • 8.3 Breast cancers
  • 8.4 Lung cancers
  • 8.5 Colorectal cancers
  • 8.6 Head & neck cancers
  • 8.7 Other applications

Chapter 9 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals
  • 9.3 Radiology clinics
  • 9.4 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 AccSys Technology, Inc.
  • 11.2 Accuray Incorporated
  • 11.3 Altair Technologies, Inc.
  • 11.4 Brainlab AG
  • 11.5 Carl Zeiss Meditec AG
  • 11.6 Elekta
  • 11.7 Laird Technologies, Inc.
  • 11.8 MITSUBISHI HEAVY INDUSTRIES, LTD.
  • 11.9 Panacea Medical Technologies Pvt. Ltd.
  • 11.10 S.I.T. Sordina IORT Technologies S.p.A.
  • 11.11 SHINVA MEDICAL INSTRUMENT CO., LTD.
  • 11.12 Siemens Healthineers AG
  • 11.13 Varian Medical Systems, Inc.
  • 11.14 VIEWRAY TECHNOLOGIES, INC.
  • 11.15 VIVIRAD S.A.